{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Delayed+Function+of+Renal+Transplant&page=2", "query": { "condition": "Delayed Function of Renal Transplant", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Delayed+Function+of+Renal+Transplant&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T10:20:25.877Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00248040", "title": "Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ischemia-Reperfusion Injury", "Kidney Diseases" ], "interventions": [ { "name": "Reparixin continuous infusion", "type": "DRUG" }, { "name": "reparixin intermittent infusion", "type": "DRUG" }, { "name": "placebo infusion", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Dompé Farmaceutici S.p.A", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 80, "start_date": "2005-10", "completion_date": "2008-06", "has_results": true, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Philadelphia, Pennsylvania", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00248040" }, { "nct_id": "NCT00235300", "title": "An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cadaveric Donor Renal Transplantation", "Acute Renal Allograft Rejection", "Induction Therapy" ], "interventions": [ { "name": "Thymoglobulin [Anti-thymocyte Globulin (rabbit)]", "type": "BIOLOGICAL" }, { "name": "Simulect (basliximab)", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Genzyme, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 240, "start_date": "2000-05", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2015-03-18", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00235300" }, { "nct_id": "NCT02134314", "title": "C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "End Stage Renal Disease", "Kidney Failure", "Delayed Graft Function", "Ischemic Reperfusion Injury" ], "interventions": [ { "name": "C1 Esterase Inhibitor", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 70, "start_date": "2014-09", "completion_date": "2017-03-13", "has_results": true, "last_update_posted_date": "2018-06-25", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02134314" }, { "nct_id": "NCT05907096", "title": "ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft Function", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Delayed Graft Function" ], "interventions": [ { "name": "ARGX-117", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "argenx", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 103, "start_date": "2024-02-17", "completion_date": "2026-07-31", "has_results": false, "last_update_posted_date": "2026-03-18", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 8, "location_summary": "Los Angeles, California • Tampa, Florida • Chicago, Illinois + 5 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Livingston", "state": "New Jersey" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05907096" }, { "nct_id": "NCT00298168", "title": "YSPSL for Prevention of Delayed Graft Function Part B", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Kidney Diseases" ], "interventions": [ { "name": "YSPSL", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Y's Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2006-05", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-01-29", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 15, "location_summary": "Los Angeles, California • San Francisco, California • Denver, Colorado + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00298168" }, { "nct_id": "NCT00970073", "title": "Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Liver Transplantation" ], "interventions": [ { "name": "Thymoglobulin 3mg total", "type": "BIOLOGICAL" }, { "name": "Thymoglobulin 4.5mg total", "type": "BIOLOGICAL" }, { "name": "Mycophenolate mofetil", "type": "DRUG" }, { "name": "tacrolimus 3-8", "type": "DRUG" }, { "name": "tacrolimus 8-12", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "The Cleveland Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2009-08", "completion_date": "2015-12", "has_results": true, "last_update_posted_date": "2018-10-09", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00970073" }, { "nct_id": "NCT04696146", "title": "Berinert (C1INH) vs Placebo for DGF/IRI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "End Stage Renal Disease", "Chronic Kidney Diseases" ], "interventions": [ { "name": "Berinert", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cedars-Sinai Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 45, "start_date": "2021-03-03", "completion_date": "2024-10-31", "has_results": true, "last_update_posted_date": "2024-12-04", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04696146" }, { "nct_id": "NCT02610296", "title": "QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Delayed Graft Function" ], "interventions": [ { "name": "QPI-1002", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Quark Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 594, "start_date": "2016-03-01", "completion_date": "2019-01-08", "has_results": false, "last_update_posted_date": "2020-05-13", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 36, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 29 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02610296" }, { "nct_id": "NCT02152345", "title": "Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Implant or Graft; Rejection" ], "interventions": [ { "name": "Belatacept", "type": "DRUG" }, { "name": "Tacrolimus", "type": "DRUG" }, { "name": "Mycophenolate", "type": "DRUG" }, { "name": "rATG", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Renal transplant", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2014-06", "completion_date": "2016-12-31", "has_results": true, "last_update_posted_date": "2021-02-10", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02152345" }, { "nct_id": "NCT00298181", "title": "YSPSL for Prevention of Delayed Graft Function Part A", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Delayed Graft Function" ], "interventions": [ { "name": "YSPSL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Y's Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2005-10", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-01-29", "last_synced_at": "2026-07-24T10:20:25.877Z", "location_count": 10, "location_summary": "Los Angeles, California • San Francisco, California • Tampa, Florida + 7 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Livingston", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00298181" } ] }